跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Pamorelin - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Pamorelin
Approved
STANDARD
Pamorelin
Debiopharm Research & Manufacturing S.A.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
a83b161c3658c73b
Company
Debiopharm Research & Manufacturing S.A.
Type
Standard
Approval Details
Approval Id
a83b161c3658c73b
Drug Approval Philippines Name
Pamorelin
Product Name
Pamorelin
Registration Number
DR-XY44246
Brand Name
Pamorelin
Generic Name
Triptorelin (as embonate)
Dosage Form
Lyophilized Powder For Injection (IM/SC)
Dosage Strength
3.75 mg
Manufacturer
Debiopharm Research & Manufacturing S.A.
Trader
Bio-ONCO, Inc.
Importer
UNILAB, Inc.
Distributor
UNILAB, Inc.
Issuance Date
27 September 2024
Expiry Date
27 February 2030
Pharmacologic Category
Antineoplastic/Gonadotropin-Releasing Hormone Analogue
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
a83b161c3658c73b
Type
Standard
Back to Philippines FDA Approvals